PillTiagabine Hydrochloride
Tiagabine Hydrochloride
1 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it1 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 6 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 4 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 15, 2026RESOLVEDShortage resolved: Tiagabine Hydrochloride Tablet (Teva Pharmaceuticals USA, Inc.)
Tiagabine Hydrochloride Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Neurology.
- Apr 15, 2026SHORTAGEDrug shortage: Tiagabine Hydrochloride Tablet (Teva Pharmaceuticals USA, Inc.)
Tiagabine Hydrochloride Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Neurology.
- Jul 10, 2023RECALLRecall (Class II): Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ …
Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Distributed nationwide in the USA.